There are three major conferences every year:
WSM, Trainee Conference and Annual Congress
High-quality anaesthesia education, in an interactive, bite-size format
Basic Transthoracic Echocardiography (TTE) & Peri-operative Ultrasound
Book your place at the first virtual WSM, 13-14 January 2021
Find out about upcoming webinars and access free COVID-19 webinar recordings
Paediatric CC and Surgical review
Wednesday 15 July
Patient Blood Management (PBM) after the COVID-19 surge
Tuesday 23 June
A guide for training programme directors in
anaesthesia and intensive care medicine
Members receive a free subscription as part of their benefits package
New guideline: Breastfeeding safe after anaesthesia
The second wave of Covid; your support in a storm.
COVID-19 intensive care mortality falls by a third
Safe Drug Management in Anaesthetic Practice
Fatigue puts you, your colleagues and your patients at risk. There are a number of ways you can help to fight the culture of fatigue in hospitals.
We've provided a list of emergency contacts for anyone in need of immediate help
Thursday 1 October 2020
The Association and the Royal College of Anaesthetists have published guidance on Safe Drug Management in Anaesthetic Practice. The guidance has been endorsed by the Royal Pharmaceutical Society (RPS), the Faculty of Intensive Care Medicine and the College of Operating Department Practitioners. ‘Safe Drug Management in Anaesthetic Practice’ builds on the 2016 guidance ‘Storage of drugs in anaesthetic rooms’, which was created in response to anaesthetists’ concerns about restrictions to their rapid access to emergency drugs occasioned by the implementation of regulations not primarily designed with the emergency management of crises that occur during anaesthesia in mind. Now the guidance has been extended beyond anaesthetic rooms to other areas where anaesthesia is administered, e.g. the Emergency Department and Labour Ward, and takes into account recently published guidance such as the RPS’s revised ‘Professional guidance on the safe and secure handling of medicines’ documents.
Since publication of the 2016 guidance, the RCoA and the Association have also received queries on issues relating to the welfare of healthcare professionals in relation to drugs used in anaesthetic practice, in particular from official bodies investigating the deaths of anaesthetists who used drugs to which they gained access at their places of work. This new guidance therefore seeks to include consideration of the safety and wellbeing of healthcare professionals by making recommendations that highlight to anaesthetists the risks relating to ‘drugs of diversion’, i.e. drugs that individuals might seek to appropriate for abuse, self-harm or sale, and that guide development of policies that ensure their safe use.
Browse, view, and download our wide range of patient safety and care guidelines
Read breaking news and the latest developments from the world of anaesthesia